The Future of Adult Cardiac Assist Devices: Novel Systems and Mechanical Circulatory Support Strategies
نویسندگان
چکیده
منابع مشابه
Heart Failure and Mechanical Circulatory Assist Devices
During the last 20 years, the management of heart failure has significantly improved by means of new pharmacotherapies, more timely invasive treatments and device assisted therapies. Indeed, advances in mechanical support, namely with the development of more efficient left ventricular assist devices (LVAD), and the total artificial heart have reduced mortality and morbidity in patients with end...
متن کاملHistory of Mechanical Circulatory Support Devices
History of Mechanical Circulatory Support Devices Advanced heart failure (HF) is a major cause of morbidity and mortality in the United States, and heart transplantation remains as the gold standard therapy. Because of scarcity of donor organs, the application of mechanical circulatory support devices has become a crucial approach in HF therapy as a bridge to transplantation. Therefore, mechani...
متن کاملNew devices for pediatric mechanical circulatory support.
PURPOSE OF REVIEW In adult patients with advanced heart failure, mechanical circulatory support devices (MCSDs) offer a valid treatment option. MCSDs can serve as a bridge to transplant, bridge to recovery or destination therapy. In the REMATCH trial, MCSDs outperformed medical management for long-term support of end-stage heart failure. Until recently, pediatric patients could not fully benefi...
متن کاملMechanical circulatory support and cardiac transplantation.
Congestive heart failure is not a specific disease but rather a clinical syndrome of diverse etiologies. This syndrome is characterized by ventricular dysfunction leading to decreased cardiac output; consequent neurohumoral activation leading to salt and water retention, with congestion in the pulmonary and systemic circulation; a “vicious circle” of blood-flow maldistribution; and eventual hyp...
متن کاملAdvances in Mechanical Circulatory Support Bleeding and Thrombosis in Patients With Continuous-Flow Ventricular Assist Devices
Because of the obligate intravascular location of contemporary continuous-flow ventricular assist devices (CFVADs), it is not surprising that bleeding and thrombosis are among the most common and feared complications of this therapy, respectively. Although strides have been made in our understanding of the pathophysiology of continuous flow, intravascular CF-VADs have been widely used only in t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cardiology Clinics
سال: 2011
ISSN: 0733-8651
DOI: 10.1016/j.ccl.2011.08.013